Fidelis Capital Partners, LLC Ptc Therapeutics, Inc. Call Options Transaction History
Fidelis Capital Partners, LLC
- $702 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding PTCT
# of Institutions
215Shares Held
79.2MCall Options Held
122KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA8.97MShares$284 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$259 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$246 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$234 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$220 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.26B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...